TWD 131.0
(-0.76%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.19 Billion TWD | -66.21% |
2022 | 4.68 Billion TWD | 69.52% |
2021 | 2.76 Billion TWD | 29.48% |
2020 | 2.13 Billion TWD | 0.0% |
2019 | 1.06 Billion TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 398.77 Million TWD | -61.89% |
2024 Q1 | 533.25 Million TWD | 206.43% |
2023 Q2 | 388.12 Million TWD | -29.5% |
2023 FY | - TWD | -66.21% |
2023 Q4 | 174.02 Million TWD | -62.91% |
2023 Q3 | 469.15 Million TWD | 20.88% |
2023 Q1 | 550.52 Million TWD | 0.46% |
2022 Q4 | 548.01 Million TWD | 0.0% |
2022 FY | - TWD | 69.52% |
2021 FY | - TWD | 29.48% |
2020 FY | - TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Medimaging Integrated Solution Inc. | 119.37 Million TWD | -898.618% |
InnoCare Optoelectronics Corporation | 95.72 Million TWD | -1145.312% |